Solving Failed Treatment for Munchausen Syndrome

Short Stays Prevent Meaningful Engagement

Consider a typical psychiatric admission for someone with Munchausen syndrome. The initial days are spent on medical workups. A psychiatric consult might occur by day four, and if fabrication is suspected, the clinical tone shifts. Often, by day seven, the patient has left, or insurance authorization has expired, leading to discharge planning.

This brief window is insufficient for the disorder’s demands. The literature explicitly states that short hospital stays limit long-term outcomes ². Building a therapeutic relationship with someone whose identity is deeply intertwined with the sick role requires weeks of consistent interaction with the same clinician, a stable routine, and firm boundaries before trust can develop.

Beyond the time constraint, short admissions typically involve a single admitting service, often medical, with psychiatry as an afterthought. However, systematic reviews of factitious disorder management emphasize the need for a comprehensive psychiatric assessment, an individualized treatment plan, a designated primary clinician, and a fully informed multidisciplinary team ⁶. These elements cannot be established within a brief stabilization period.

The failure is structural, not personal. Comparing standard short-stay admissions with extended-stay, psychiatry-led models reveals four key differences:

• the duration available for engagement,
• the primary treatment modality (medical stabilization versus psychotherapy),
• the coordination of the interprofessional team, and
• the outcome pattern (frequent discharges against medical advice ³ versus sustained follow-up).

These distinctions are crucial for effective care.

Medication-First Approaches Miss the Core Behavior

Families often observe prescribers attempting to address factitious disorder with medication—new antidepressants, antipsychotics, or mood stabilizers. Despite these interventions, fabricated symptoms frequently recur, sometimes in new forms or with new specialties in different locations.

This isn’t due to prescriber negligence but reflects the evidence base, which points to treatment approaches not typically integrated into acute care. Clinical literature highlights three central findings:

1. first, psychotherapy is the only currently effective treatment for factitious disorder ⁴.
2. Second, standard psychiatric medications, including antidepressants and antipsychotics, show no direct benefit for the factitious behavior itself ⁹. While they can treat co-occurring depression or psychotic symptoms, they do not impact the fabrication pattern.
3. Third, long-term psychotherapy and follow-up are consistently recommended ³.

This creates a clear mismatch: standard programs prioritize medication management, symptom stabilization, and short authorization windows. However, the disorder responds to sustained relational work over months, delivered by clinicians who can maintain engagement without requiring rapid symptom improvement. When medication is the primary focus, psychotherapy becomes a secondary activity, often scheduled infrequently with available therapists, which contradicts research-backed approaches and negatively impacts outcomes.

The Cycle of Non-Adherence and AMA Discharges

One of the most challenging aspects for families is that even in well-designed programs with skilled clinicians, most patients with this diagnosis decline or drop out of therapy ⁵, ⁴. This pattern is a defining feature of the disorder within the field.

In practice, this manifests as a familiar cycle: an admission starts well, but as a clinician approaches the underlying pattern, a lab result contradicts a symptom, or a family visit creates discomfort, the patient leaves. Clinical literature directly notes that adherence to treatment plans is generally suboptimal, and patients frequently leave against medical advice ³. The next admission often begins elsewhere, without access to previous records, restarting the cycle.

This cycle is not a result of family actions but an inherent characteristic of the disorder operating within a system designed for simpler problems. Progress in this diagnosis is often subtle: staying past the first therapy session, returning after leaving, or agreeing to see the same psychiatrist twice. These are significant markers of progress, as they represent entry points to the long-term engagement essential for any further therapeutic work.

Consistent Clinician and Coordinated Team

Families often observe their loved one cycling through numerous clinicians across multiple hospitalizations, each hearing a different version of their story. This fragmentation undermines consistent care.

Systematic reviews of factitious disorder management recommend a comprehensive psychiatric assessment, an individualized treatment plan, a designated primary clinician, and a fully informed multidisciplinary team ⁶. These elements are designed to function as an integrated structure.

In practice, this means a single psychiatrist oversees the case from admission through discharge and follow-up. The therapist is aware of medication discussions, medical clinicians know previous symptom workups, preventing redundant referrals, and social workers and family contacts are kept informed. This integrated approach ensures a shared understanding of the patient’s pattern.

Munchausen syndrome is best managed by an interprofessional team including a psychiatrist, psychologist, primary care provider, social work, and nursing staff ⁹. Such a team provides a consistent, honest picture of the patient’s condition, maintained by professionals who will remain involved long-term. When a patient tests boundaries, the team responds with a unified, informed approach.

Time as a Therapeutic Element

While length of stay is often viewed as a cost factor, for factitious disorder, it is a crucial therapeutic ingredient. Research consistently supports long-term psychotherapy and follow-up ³, indicating that patients who persist in long-term therapy achieve more favorable outcomes ⁴. Such persistence is impossible within a typical seven-day authorization.

An extended-stay model redefines the role of time. The initial weeks are foundational, allowing the designated psychiatrist to become a familiar figure. This period enables the patient to test boundaries, observe staff responses, and recalibrate within a consistent environment. Face-saving, stepwise work on underlying behaviors becomes possible only after this groundwork, which often takes weeks ⁷.

Historically, some literature recommended long-term, sometimes closed-ward settings for Munchausen syndrome ¹⁰, a recommendation now controversial regarding autonomy. However, a modern extended-stay model is voluntary, with individualized care duration determined by clinical need, not insurance timelines. Patients can still leave, but the program and its consistent team remain available if they return or choose to stay. This structure offers a different kind of opportunity than a short-term stabilization bed.

Integrated Treatment of Comorbidities

A critical insight is that the prognosis for Munchausen syndrome is influenced more by co-occurring conditions than by the fabrication pattern itself. Comorbid depression, anxiety, and substance use disorders are common, and patients with these comorbidities may have better long-term outcomes than those with personality disorders as their primary comorbidity ⁹. The presence of comorbid psychiatric conditions significantly shapes the clinical course ⁵, necessitating a treatment approach that addresses these factors.

If a patient has been self-medicating with alcohol or drugs, or struggling with untreated depression or trauma, these are not secondary issues but integral parts of the treatment. A dual-diagnosis program, where psychiatric and substance use treatment are integrated within the same team, aligns with evidence-based recommendations.

This approach also clarifies the role of medication. While antidepressants and antipsychotics do not treat factitious behavior, they can effectively treat co-occurring depression or psychotic symptoms. Psychiatry-led care ensures that medication decisions are based on the patient’s complete clinical picture, not just the most prominent symptom. Prioritizing psychiatric care and reducing unnecessary medical procedures is a consistent recommendation in liaison psychiatry literature ¹.